Harrisburg, NC -- (SBWIRE) -- 10/11/2018 -- The global neuroendovascular coil and non-coil devices market is estimated at US$ XX Billion in 2016 and projected to reach US$ XX Billion by 2021, growing at a CAGR of XX% during the forecast period.
Cerebrovascular diseases include some of the most common and devastating disorders: ischemic stroke and hemorrhagic stroke. According to the World Health Organization, 15 Million people suffer stroke worldwide each year. Of these, 5 Million die and another 5 Million are permanently disabled. Stroke is the third leading cause of death in the United States. More than 140,000 people die each year from stroke in the United States. The incidence of cerebrovascular diseases increases with age, and the number of strokes is projected to increase as the elderly population grows, with a doubling in stroke deaths in the United States by 2030.
Buy complete research data at:
Drivers & Restraints
Market growth can be attributed to factors such as rising prevalence of cerebrovascular disease and its associated risk factors, rise in the number of aging population, increasing knowledge of the symptoms of aneurysms and related diseases among patients, next generation of device platforms enters the market, long-term clinical data become available, appropriate treatment guidelines and reimbursement rates are established. Rapid advances in the field of neuroendovascular devices and development of minimally invasive techniques have greatly expanded the market. High cost of treatment, unmet needs, scarcity of skilled neurosurgeons is restraining the growth of neuroendovascular coil & non-coil devices market.
Coil represented the largest single category of products and accounted for XX% share in 2015. However, growth rate has slowed down in the segment which is being challenged by the emerging Carotid Stent, Microwire/Catheter and Clot Removal device. These three major devices grabbed the market share of XX% in 2015. It is expected that Coil will lead the neuroendovascular coil & non-coil devices market with XX% market share by the end of 2021.
United States is seen as the dominant player in the neuroendovascular coil & non-coil devices market. Emerging economies of India, China and Japan in the Asia-Pacific region and Latin American countries such as Brazil is slated to witness the highest growth in the forecasted period. The growth of the Asia-Pacific market is driven by improving healthcare facilities, gross domestic product (GDP) and increasing government investment.
For More Details Inquire at:
Prudent analysis has been done on the competitor's part, where four major players grab XX% of the global market by revenue. Stryker, Medtronic, Terumo, and DePuy Synthes are the key influencers with their products in the neuroendovascular coil & non-coil devices market. New releases, merger & acquisitions, collaborations and extending distribution networks are few important factors for their dominance.
The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry validated market data. It also contains projection using a suitable set of assumptions and methodologies. The research report provides analysis and information according to categories such as market segments, diseases, geographies, companies, price trend, pipeline products, type of coil & non-coil devices and competitive landscape. The report concludes with the profiles of major players in the global neuroendovascular coil & non-coil devices market such as Stryker, Medtronic, Terumo, and DePuy Synthes. The major market players are evaluated on various parameters such as company overview, product portfolio, and sales figures of neuroendovascular coil & non-coil devices segment from 2012 to 2021. The report also entails major drivers and challenges of neuroendovascular coil & non-coil devices market.
Neuroendovascular coil & non-coil devices market can be segmented based on
Based on Device, the global neuroendovascular coil & non-coil devices market can be segmented as follows:
Coil Assist Balloon
Coil Assist Stent
Flow Diverter Stent
Based on Disease, the global neuroendovascular coil & non-coil devices market can be segmented as follows:
Intracranial Atherosclerotic Disease (ICAD)
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Browse Full Report at:
Reasons to Purchase this Report
- Identify the current and future prospect of the Neuroendovascular Coil and Non-Coil Devices market in the developed and emerging markets
- Analyze various perspectives of the market with the help of Porter's five forces analysis
- Information about the growth of the various material, type, and application that are expected to dominate the market
- Regional and country analysis of the market
- Identify the latest developments, market shares, and strategies employed by the major market players
- 3 months analyst support, along with the Market Estimate sheet (in Excel)
About Us: -
MarketInsightsReports provides syndicated market research reports to industries, organizations or even individuals with an aim of helping them in their decision making process. These reports include in-depth market research studies i.e. market share analysis, industry analysis, information on products, countries, market size, trends, business research details and much more. MarketInsightsReports provides global and regional market intelligence coverage, a 360-degree market view which includes statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.
+1 (704) 266-3234 |firstname.lastname@example.org
Connect with us on: